PIP4K and the role of nuclear phosphoinositides in tumour suppression

Biochimica Et Biophysica Acta
Roberta FiumeNullin Divecha

Abstract

Phosphatidylinositol-5-phosphate (PtdIns5P)-4-kinases (PIP4Ks) are stress-regulated lipid kinases that phosphorylate PtdIns5P to generate PtdIns(4,5)P₂. There are three isoforms of PIP4Ks: PIP4K2A, 2B and 2C, which localise to different subcellular compartments with the PIP4K2B isoform being localised predominantly in the nucleus. Suppression of PIP4K expression selectively prevents tumour cell growth in vitro and prevents tumour development in mice that have lost the tumour suppressor p53. p53 is lost or mutated in over 70% of all human tumours. These studies suggest that inhibition of PIP4K signalling constitutes a novel anti-cancer therapeutic target. In this review we will discuss the role of PIP4K in tumour suppression and speculate on how PIP4K modulates nuclear phosphoinositides (PPIns) and how this might impact on nuclear functions to regulate cell growth. This article is part of a Special Issue entitled Phosphoinositides.

References

Jan 1, 1990·Journal of Neurochemistry·A MoritzK W Wirtz
Jan 16, 1985·Biochemical and Biophysical Research Communications·L A Van RooijenN G Bazan
Feb 17, 1995·The Journal of Biological Chemistry·I V Boronenkov, R A Anderson
Mar 15, 1993·The Biochemical Journal·H BanfićR F Irvine
Jan 1, 1996·Advances in Enzyme Regulation·J C LoijensR A Anderson
Jul 30, 1997·Biochemical and Biophysical Research Communications·H BadingS Chawla
Mar 7, 2002·Proceedings of the National Academy of Sciences of the United States of America·Oliver J RandoGerald R Crabtree
Nov 16, 2002·Science·David J StegerErin K O'Shea
Feb 28, 2003·Proceedings of the National Academy of Sciences of the United States of America·M F LeiteM H Nathanson
Apr 30, 2003·Nature Cell Biology·Wihelma EchevarríaMichael H Nathanson
Aug 5, 2003·Proceedings of the National Academy of Sciences of the United States of America·Valerie CarricaburuLucia E Rameh
Dec 18, 2004·Science·Adolfo SaiardiSolomon H Snyder
Apr 12, 2005·Annual Review of Pharmacology and Toxicology·Manel Esteller
Jun 20, 2006·Nature Cell Biology·Abel R Alcázar-RománSusan R Wente
Sep 5, 2006·Molecular Cell·David R JonesNullin Divecha
Aug 4, 2007·Science·Magnolia BostickSteven E Jacobsen
Aug 21, 2007·Genes & Development·Maria Divina E Deato, Robert Tjian
Oct 18, 2007·Proceedings of the National Academy of Sciences of the United States of America·Jun ZouPhilip W Majerus
May 17, 2008·Cancer Research·Tamer T OnderRobert A Weinberg
Jun 20, 2008·Proceedings of the National Academy of Sciences of the United States of America·Masashi OkadaKeqiang Ye
Sep 12, 2008·The EMBO Journal·Mariella VicinanzaMaria Antonietta De Matteis
Sep 17, 2008·Oncogene·T L Yuan, L C Cantley

❮ Previous
Next ❯

Citations

Dec 30, 2015·Advances in Biological Regulation·Maria-Luisa GiudiciRobin F Irvine
Aug 1, 2015·Blood Cells, Molecules & Diseases·Keli LimaJoão Agostinho Machado-Neto
Dec 3, 2015·Journal of Cellular Physiology·Alessandro PoliGiulia Ramazzotti
May 3, 2016·Trends in Biochemical Sciences·Roberta FiumeNullin Divecha
Jun 21, 2016·Epigenomics·Sarah Kreuz, Wolfgang Fischle
Mar 4, 2017·Journal of Cellular Physiology·Bree L Hamann, Raymond D Blind
Nov 3, 2016·Journal of Lipid Research·Robin F Irvine
Jun 4, 2016·Journal of Lipid Research·Emily K TribbleVytas A Bankaitis
Apr 5, 2019·Science Advances·Sergio BoteroSanford M Simon
Sep 4, 2019·Cell Biochemistry and Function·Javier Adrian MoralesEnrique Castano
Nov 11, 2019·G3 : Genes - Genomes - Genetics·Vishnu JanardanPadinjat Raghu
Mar 23, 2019·The Journal of Experimental Medicine·Yong Jae ShinDo-Hyun Nam
Sep 12, 2019·Frontiers in Molecular Neuroscience·Padinjat RaghuSankhanil Saha
May 1, 2019·International Journal of Molecular Sciences·Alessandro PoliNullin Divecha
Oct 28, 2019·Bioscience Reports·Avishek GhoshPadinjat Raghu
May 19, 2021·Proceedings of the National Academy of Sciences of the United States of America·Song ChenYa Ha
Mar 5, 2020·Cell Chemical Biology·Sindhu Carmen SivakumarenNathanael S Gray
Jun 19, 2021·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Oksana GoroshchukCaroline Palm-Apergi
Jul 27, 2021·Current Opinion in Chemical Biology·Timothy B Ware, Ku-Lung Hsu
Aug 24, 2021·Frontiers in Pharmacology·Olivier Preynat-SeauveKarl-Heinz Krause
Nov 26, 2021·FEBS Letters·Gurpreet K AroraBrooke M Emerling

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Liza Bundesen
Journal of Social Work in End-of-life & Palliative Care
Mary Beth Morrissey, Bruce Jennings
Bioorganicheskaia khimiia
A G Gabibov, V M Govorun
Archives of Biochemistry and Biophysics
F Peter Guengerich
© 2022 Meta ULC. All rights reserved